Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic

Transfusion

Volumn 45, Issue 4, 2005, Pages 480-486

  Tobler, Leslie H ^a   Bianco, C ^b   Glynn, S A ^b   Schreiber, G B ^b   Dille, B J ^b   Prince, H E ^b   Lanciotti, R S ^b   Linnen, J M ^b   Gallarda, J ^b   Shyamala, V ^b   Smith, D ^b   Kleinman, S H ^b   Busch, M P ^b  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS RNA;

ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; AUTUMN; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EPIDEMIC; FOOD AND DRUG ADMINISTRATION; FREEZING; HUMAN; INFECTION RISK; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PLASMA; RNA ANALYSIS; SUMMER; VIREMIA; VIRUS INFECTION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

ANTIBODIES, VIRAL; BLOOD BANKS; CONSUMER PRODUCT SAFETY; DISEASE OUTBREAKS; HUMANS; INCIDENCE; PLASMA; RISK FACTORS; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 20144388436     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2005.04266.x     Document Type: Article

References (19)

1. Hubalek Z, Halouzka J. West Nile fever - a reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis 1999;5:643-50.
2. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001;344:1807-14.
3. Roehrig JT, Layton M, Smith P, et al. The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr Top Microbiol Immunol 2002;267:223-40.
4. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003;349:1236-45.
5. FDA News: Statement on blood industry's voluntary market withdrawal of certain frozen blood products to reduce risk of west nile virus transmission from transfusion [Internet]. Rockville (MD): Office of Public Affairs, U.S. Food and Drug Administration; 2002 Dec 12. Available from: http://www.fda.gov/bbs/ topics/NEWS/2002/NEW00857.html
6. Hollinger FB, Kleinman S. Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectives. Transfusion 2003;43:992-7.
7. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003;349:1205-6.
8. Prince HE, Lape'-Nixon M, Moore RJ, Hogrefe WR. Utility of the focus technologies west nile virus immunoglobulin M capture enzyme-linked immunosorbent assay for testing cerebrospinal fluid. J Clin Microbiol 2004;42:12-5.
9. Davis BS, Chang GJ, Cropp B, et al. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J Virol 2001;75:4040-7.
10. Prince HE, Hogrefe WR. Detection of West Nile virus (WNV) - specific immunoglobulin M in a reference laboratory setting during the 2002 WNV season in the United States. Clin Diagn Lab Immunol 2003;10:764-8.
11. Ratterree MS, Gutierrez RA, Travassos da Rosa AP, et al. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J Infect Dis 2004;189:669-76.
12. Giachetti C, Linnen JM, Kolk DP, et al. Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 2002;40:2408-19.
13. Kacian DL, Fulz TJ. Nucleic acid sequence amplification methods. US patent 5,399,491. 1995.
14. Arnold LJ Jr, Hammond PW, Wiese WA, Nelson NC. Assay formats involving acridinium-ester-labeled DNA probes. Clin Chem 1989;35:1588-94.
15. Majlessi M, Nelson NC, Becker MM. Advantages of 2′-O-methyl oligoribonucleotide probes for detecting RNA targets. Nucleic Acids Res 1998;26:2224-9.
16. Beaty BJ, Calisher CH, Shope RE. Arboviruses. In: Schmidt NJ, Emmons RW, eds. Diagnostic procedures for viral, rickettsial and chlamydial infections. Washington (DC): American Public Health Association; 1989. p. 797.
17. Caglioti S, McAuley J, Robertson GF, et al. Relative yield of mini-pool versus individual donation NAT for West Nile virus RNA [abstract]. Transfusion 2004;44(Suppl):6A.
18. Centers for Disease Control and Prevention (CDC). Update: West Nile virus screening of blood donations and transfusion-associated transmission - United States, 2003. MMWR Morb Mortal Wkly Rep 2004;53:281-4.
19. Custer B, Tomasulo P, Murphy EL, et al. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion 2004;44:1547-54.